Kevin Tan serves as Executive at SELECTA BIOSCIENCES INC, where they oversee executive responsibilities. Since joining the company, Kevin Tan has executed 7 insider transactions totaling $77.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 13, 2026 involved selling 5,704 shares valued at $30.1K.
Kevin Tan currently holds 46,100 shares of SELECTA BIOSCIENCES INC (SELB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Tan has been a net seller of SELB stock. They have purchased $15.2K and sold $62.3K worth of shares.
Kevin Tan's most recent insider trade was on Jan 13, 2026, when they sold 5,704 shares at $5.27 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 9, 2026 | SLDB | $0 | Option Exercise | 11,250 | $N/A | Discretionary |
| Jan 9, 2024 | SLDB | $0 | Option Exercise | 11,250 | $N/A | Discretionary |
| Jan 9, 2024 | SLDB | $32.3K | Sale | 3,935 | $8.20 | Discretionary |
| Jan 3, 2022 | SELB | $0 | Award | 72,000 | $N/A | Discretionary |
| Dec 2, 2021 | SELB | $15.2K | Purchase | 5,000 | $3.03 | Discretionary |